(Total Views: 83)
Posted On: 07/31/2019 8:25:41 AM
Post# of 47082

$SLS News Article - SELLAS Advances Galinpepimut-S (GPS) in Combination with KEYTRUDA (pembrolizumab) Program with Dosing of First Patient in Phase 1/2 Basket Study https://marketwirenews.com/news-releases/sell...96729.html


My Twitter: WhyteStocks
Scroll down for more posts ▼